🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
To evaluate the safety and tolerance of the combination of adefovir dipivox...
Status
Completed
Location
Phoenix Body Positive
Start Date
TBD
Trial ID
NCT00002184
Treatments Being Tested
This study will assess the pharmacokinetics of TDF in Thai HIV-infected chi...
Status
Completed
Location
Khon Kaen University
Start Date
2010-06
Trial ID
NCT02404259
Treatments Being Tested
This open-label study will evaluate the safety, pharmacokinetics and antivi...
Status
Completed
Location
Multiple Locations
Start Date
2012-01
Trial ID
NCT01638650
Treatments Being Tested
This is a pilot study investigating the efficacy of Doravirine (DOR) in com...
Status
Unknown
Location
Charlotte Maxeke Johannesburg Academic Hospital
Start Date
2021-02-09
Trial ID
NCT04429152
Treatments Being Tested
The primary objectives of this study are to evaluate the antiretroviral act...
Status
Completed
Location
Multiple Locations
Start Date
2016-01-14
Trial ID
NCT02629822
Treatments Being Tested
This study will be a two-arm prospective 1:1 randomised controlled trial co...
Status
Completed
Location
Brighton and Sussex University Hospitals NHS Trust
Start Date
2015-11-27
Trial ID
NCT02336074
Anti-HIV treatment consisting of lamivudine/zidovudine (3TC/ZDV) and efavir...
Status
Completed
Location
Les Centres GHESKIO CIPRA CRS
Start Date
2007-07
Trial ID
NCT00120510
Treatments Being Tested
To evaluate the safety and immunogenicity of HIV-1 MN rgp160 (Immuno-AG) in...
Status
Completed
Location
Stanford CRS
Start Date
TBD
Trial ID
NCT00000822
Treatments Being Tested
This is a 96 week study to determine if UK- 453,061 in combination with Dar...
Status
Terminated
Location
Jeffrey Goodman Special Care Clinic
Start Date
2009-03-25
Trial ID
NCT00823979
Treatments Being Tested
Dolutegravir (DTG) is a well-tolerated 2nd generation integrase strand tran...
Status
Completed
Location
GSK Investigational Site
Start Date
2019-11-18
Trial ID
NCT04019873
Treatments Being Tested